C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 249/12 (2006.01) A61K 31/4196 (2006.01) A61P 35/00 (2006.01) C07F 9/09 (2006.01) C07H 15/26 (2006.01)
Patent
CA 2675737
5-[4-(2-Methyl-phenyl)-3-hydroxy-4H-[1,2,4]triazol-5-yl]-2,4-dihydroxy-.LAMBDA./- methyl-.LAMBDA./-butyl-benzamide is an HSP90 inhibitor and can be used for producing a medicament for treating diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
Le 5-[4-(2-méthyl-phényl)-3-hydroxy-4H-[1,2,4]triazol-5-yl]-2,4-dihydroxy-N-méthyl-N-butyl-benzamide est un inhibiteur de HSP90 et peut être utilisé pour produire un médicament destiné à traiter des maladies dans lesquelles l'inhibition, la régulation et/ou la modulation de HSP90 jouent un rôle.
Buchstaller Hans-Peter
Eggenweiler Hans-Michael
Sirrenberg Christian
Wolf Michael
Fetherstonhaugh & Co.
Merck Patent Gesellschaft Mit Beschraenkter Haftung
LandOfFree
Triazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivative will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1647739